CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-09-15 | ALLEN CORINNE E Chief Financial Officer | Gift | −81,000 | 1,038,071 | ||
| 2010-01-15 | Van Ness Kenneth CEO & President | Sale | −300 | $1.93 | $579 | 1,929,041 |
| 2010-01-13 | Dembow George F Director | Grant or award · Options (right to acquire) | +50,000 | 50,000 | ||
| 2010-01-13 | TROPP RONALD J Director | Grant or award · Options (right to acquire) | +100,000 | 100,000 | ||
| 2010-01-13 | Naydenov Jordan G Director | Purchase · Series B Convertible Preferred Stock | +20,000 | $5.00 | $100K | 60,000 |
| 2010-01-13 | Naydenov Jordan G Director | Grant or award · Options (right to buy) | +75,000 | 75,000 | ||
| 2010-01-13 | GOULD GREGORY A Director | Grant or award · Options (right to acquire) | +125,000 | 125,000 | ||
| 2010-01-11 | Van Ness Kenneth CEO & President | Sale | −5,000 | $1.95 | $10K | 1,929,341 |
| 2010-01-06 | Van Ness Kenneth CEO & President | Sale | −4,242 | $1.80 | $8K | 1,934,341 |
| 2010-01-05 | Van Ness Kenneth CEO & President | Sale | −1,400 | $1.78 | $2K | 1,938,583 |
| 2010-01-04 | Van Ness Kenneth CEO & President | Sale | −5,000 | $1.75 | $9K | 1,939,983 |
| 2009-12-29 | Van Ness Kenneth CEO & President | Sale | −2,557 | $1.69 | $4K | 1,944,983 |
| 2009-12-22 | Van Ness Kenneth CEO & President | Sale | −500 | $1.66 | $830 | 1,947,540 |
| 2009-11-13 | ALLEN ALLEN D Chief Executive Officer | Sale | −300,000 | $0.50 | $150K | 1,403,515 |
| 2009-10-26 | Van Ness Kenneth CEO & President | Sale | −7,000 | $1.32 | $9K | 1,948,040 |
| 2009-10-23 | Van Ness Kenneth CEO & President | Sale | −6,535 | $1.13 | $7K | 1,955,040 |
| 2009-10-22 | Van Ness Kenneth CEO & President | Sale | −2,805 | $1.10 | $3K | 1,961,575 |
| 2009-10-19 | Van Ness Kenneth CEO & President | Sale | −1,739 | $1.08 | $2K | 1,964,380 |
| 2009-10-16 | Van Ness Kenneth CEO & President | Sale | −18,940 | $1.02 | $19K | 1,966,119 |
| 2009-10-07 | Dembow George F Director | Purchase · Series B Convertible Preferred Stock | +5,000 | $5.00 | $25K | 5,000 |
Page 45 of 48 · 951 trades